Clinical studies recruiting near Vejle

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Vejle Sygehus. ( Site 3205) · Merck Sharp & Dohme LLC · NCT06393374 OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer
Phase 2 · Department pf Oncology, Vejle Hospital · Karen-Lise Garm Spindler · NCT04680260 FRAME - Implementation of a PRO Measure to Inform Patient-Centered Survivorship Care in Oncology Outpatient Visits
NA · Department of Oncology, Vejle Hospital, University Hospital · Vejle Hospital · NCT07281820 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Sanos Vejle · Amgen · NCT07037433 DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies
Phase N/A · Vejle Hospital · University of Aarhus · NCT06076811 Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients
Phase 3 · Department of Oncology, Vejle Hospital · Vejle Hospital · NCT04095299 Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection
NA · Lillebaelt Hospital Vejle, University Hospital of Southern D · Vejle Hospital · NCT07552584 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Vejle Sygehus · Eli Lilly and Company · NCT06937086 Reducing Breathlessness With Dronabinol in COPD Patients
Phase 3 · Vejle Hospital - A part of Lillebaelt Hospital · Vejle Hospital · NCT06473701 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Sanos Clinic - Syddanmark · Eli Lilly and Company · NCT07353931 Protons Vs. Photons for High-risk Prostate Cancer
NA · Department of Oncology, Vejle Hospital, Denmark · University of Aarhus · NCT05350475 The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer
NA · Vejle Hospital · Danish Breast Cancer Cooperative Group · NCT04291378 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Vejle Sygehus · Pfizer · NCT06629779 FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NA · Lille Baelt Hospital · Odense University Hospital · NCT06877949 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site DK002 · Incyte Corporation · NCT07522073 Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease
NA · Lillebaelt Hospital Vejle - University Hospital of Southern · Esbjerg Hospital - University Hospital of Southern Denmark · NCT06882993 Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Phase 2 · Research Site · AstraZeneca · NCT06526793 Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease
NA · Lillebælt syge - Vejle Sygehus · Christoffer Johansen · NCT05444348 The ctDNA-RECIST Trial Part One
Phase 2 · Department pf Oncology, Vejle Hospital · Karen-Lise Garm Spindler · NCT06562348 A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Te
Phase 2 · Vejle Sygehus /ID# 274368 · AbbVie · NCT07023289 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site DK45006 · Astellas Pharma Global Development, Inc. · NCT02960022 A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compar
Phase 3 · GC2501 Study Site 150 · Grifols Therapeutics LLC · NCT07555483 A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chro
Phase 4 · Investigational Site Number : 2080002 · Sanofi · NCT07053423 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Vejle Sygehus ( Site 0653) · Merck Sharp & Dohme LLC · NCT03486873 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Vejle Sygehus · Pfizer · NCT07222800 Strategies for Defibrillation During Out-of-Hospital Cardiac Arrest
NA · Emergency Medical Services, the Region of Southern Denmark · Lars Wiuff Andersen · NCT06781892 A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in
Phase 3 · Vejle Sygehus · Nordic Lymphoma Group · NCT04332822 Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Ob
Phase 3 · Vejle Sygehus · Eli Lilly and Company · NCT06937099 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · Vejle Sygehus · Janssen Research & Development, LLC · NCT05552222

Look up another city

Look up another condition